FDA Approved: TIVDAK — Supplemental Application (SEAGEN INC.)

View source ↗

Summary

The FDA approved Seagen's supplemental application for TIVDAK (tisotumab vedotin), resulting in updated labeling to reflect the approved indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• TIVDAK (tisotumab vedotin)

Snippet

SUPPL AP for TIVDAK (TISOTUMAB VEDOTIN)